Dissolve Pain in Seconds: The Advantage of F-MELT®in Lornoxicam Fast Disintegrating Tablets

Introduction

Revolutionizing Pain Relief for Rheumatoid Arthritis (RA)

Lornoxicam, a potent NSAID, is widely used for rapid pain relief in rheumatoid arthritis. However, its poor water solubility (BCS II) and bitter taste have historically limited its effectiveness in fast disintegrating tablet (FDT) formulations.

Recent advances using F-MELT®, by Fuji Chemical Industries, and optimized superdisintegrant strategies have transformed the landscape, enabling rapid onset, improved patient compliance, and superior bioavailability.

F-MELT®: The Game-Changer int FDT Technologoy

What is F-MELT® ?

F-MELT® is a co-processed excipient specifically designed for fast disintegration and dissolution in oral solid dosage forms. It combines multiple functional ingredients to deliver:

Ultra-fast disintegration
Excellent mouthfeel
Superior compressibility
Enhanced stability

Why F-MELT® for Lornoxicam FDTs?

In the referenced study (Moutasim et al., 2017b), F-MELT® Type C was pivotal in achieving a disintegration time as low as 13.37 seconds in vivo and 18 seconds in vitro for the optimized lornoxicam FDT (Formula F2) (Containing 20% of drug complex, 73.67% of F-MELT® Type C, 4.17% of Crospovidone, 0.83% of Monoammonium glycyrrhizinate, 1% of Menthol, and 0.33% of magnesium stearate). This rapid breakdown ensures that drug is quickly available for absorption, providing fast pain relief.

Formulation Highlights: Lornoxicam FDTs with F-MELT®

Key Ingredients in Optimized Formula (F2)

Performance Metrics

Disintegration Time:
13 sec. (in vivo), 18 sec. (in vitro)
Dissolution:
95.9% drug release in 6 minutes
Bioavailability:
105.49% relative to reference (Zeficam®)
Palatability:
Rated as highly acceptable by volunteers

Study Insights

The combination of F-MELT® Type C and crospovidone in F2 resulted in the shortest disintegration and highest dissolution rates among all tested formulations. This synergy is essential for drugs like lornoxicam, where rapid onset is crucial.

Why Choose F-MELT® Lornoxicam FDTS?

Fastest Onset of Action:
Ideal for acute pain management in RA and postoperative settings

Bioequivalent to Marketed Brands:
Demonstrated comparable or superior pharmacokinetics to Zeficam®.

Superior Patient Compliance:
No water needed, pleasant taste, and easy administration for all age groups.

Palatability and Acceptance:
Volunteers rated the lornoxicam FDTs containing F-MELT® type C as highly palatable, overcoming the bitterness challenge.

Conclusion

Setting a New Standard in Fast Disintegrating Tablets

F-MELT®-based lornoxicam FDTs represent a significant advancement in oral drug delivery, offering rapid disintegration, enhanced dissolution, and improved patient satisfaction. The strategic use of platform technologies such as F-MELT® is key to unlocking these benefits, making this formulation a compelling choice for both patients and healthcare providers.

Continue reading and see the full Pharmaceutical Technical Newsletter on Dissolve Pain in Seconds: The Advantage of F-MELT®in Lornoxicam Fast Disintegrating Tablets here:

(click the picture to download the technical newsletter)

Do you need more information or a sample of Fuji Chemical Industries excipients?

Name *

First

Last

Email *

Company *

Address

Address Line 1

Address Line 2

City

State / Province / Region

Postal Code

Country

Comment or Message *

I agree with the privacy policy as per https://www.pharmaexcipients.com/privacy/ . The contact details will be shared with the supplier who holds the request above. The supplier can contact you directly.

Phone

excipients formulation